Posted on June 7, 2009 by Sitemaster
Today’s news reports deal with:
- Diabetes, PSA, and prostate cancer risk
- Magnetic resonance spectroscopic imaging
- Ongoing trials of dutasteride as early stage treatment for prostate cancer … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment, Uncategorized | Tagged: ARTS, diabetes, dutasteride, magmentic resonance spectroscopic imaging, MSRI, REDEEM, risk | Leave a comment »
Posted on November 5, 2008 by Sitemaster
Today’s news addresses such issues as:
- The potential of MRI/MSRI in the decision to treat men with low-risk, localized prostate cancer
- Understaging of older patients with high PSA levels
- Relative effectiveness and safety of LRP and RALP
- An experimental technique called “irreversible electroporation”
- The use of RALP in treatment of obese men … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: electroporation, LRP, MRI, MSRI, obese, RALP, understaging | Leave a comment »